Skip to main content
Livermore
Livermore
ZHEN

Dimensional Fund Advisors LP

SEC CIK
0000354204
Latest filing
Aug 11, 2026

VKTX holding history

Viking Therapeutics, Inc. in every 13F filed by Dimensional Fund Advisors LP, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

VKTX overviewAll 13F holders of VKTXFull Q2 2026 holdings

Shares (Q2 2026)
540,053
Value
$21.1M
% of portfolio
<0.1%
Quarters held
21
Since Q1 2021
Holdings of VKTX by Dimensional Fund Advisors LP, by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 2026540,053$21.1M<0.1%−2,463−0.5%ReducedHolders
Q1 2026542,516$17.7M<0.1%+82,941+18.0%AddedHolders
Q4 2025459,575$16.2M<0.1%−11,684−2.5%ReducedHolders
Q3 2025471,259$12.4M<0.1%+235,189+99.6%AddedHolders
Q2 2025236,070$6.26M<0.1%+236,070NewHolders
Q1 20250$00.0%−100,762−100.0%Sold outHolders
Q4 2024100,762$4.05M<0.1%−10,394−9.4%ReducedHolders
Q3 2024111,156$7.04M<0.1%+64,266+137.1%AddedHolders
Q2 202446,890$2.49M<0.1%−262−0.6%ReducedHolders
Q1 202447,152$3.87M<0.1%−14,981−24.1%ReducedHolders
Q4 202362,133$1.16M<0.1%−364,631−85.4%ReducedHolders
Q3 2023426,764$4.73M<0.1%−107,568−20.1%ReducedHolders
Q2 2023534,332$8.66M<0.1%00.0%UnchangedHolders
Q1 2023534,332$8.90M<0.1%−314,395−37.0%ReducedHolders
Q4 2022848,727$7.98M<0.1%−65,236−7.1%ReducedHolders
Q3 2022913,963$2.49M<0.1%−369,962−28.8%ReducedHolders
Q2 20221,283,925$3.71M<0.1%−91,560−6.7%ReducedHolders
Q1 20221,375,485$4.13M<0.1%+312,377+29.4%AddedHolders
Q4 20211,063,108$4.89M<0.1%+296,385+38.7%AddedHolders
Q3 2021766,723$4.82M<0.1%+430,845+128.3%AddedHolders
Q2 2021335,878$2.01M<0.1%+23,474+7.5%AddedHolders
Q1 2021312,404$1.98M<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.